Licensing in Pharma - Value Creation and Appropriation
We unify literature on licensing in the pharmaceutical industry and empirically verify pre-established and identify new determinants of value creation and appropriation based on a contemporary data set of licensing deals made between 2015 and 2020. We observe positive returns for licensor and licensee. A return differential indicates value appropriation by the licensor due to scarcity. A positive